These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3723356)

  • 1. Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules.
    Rollot JM; Couvreur P; Roblot-Treupel L; Puisieux F
    J Pharm Sci; 1986 Apr; 75(4):361-4. PubMed ID: 3723356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyalkyl cyanoacrylate nanocapsules.
    el-Samaligy MS; Rohdewald P; Mahmoud HA
    J Pharm Pharmacol; 1986 Mar; 38(3):216-8. PubMed ID: 2871158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro heterogeneous degradation of poly(n-alkyl alpha-cyanoacrylates).
    Vezin WR; Florence AT
    J Biomed Mater Res; 1980 Mar; 14(2):93-106. PubMed ID: 7188940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(alkylcyanoacrylate) nanocapsules: physicochemical characterization and mechanism of formation.
    Chouinard F; Buczkowski S; Lenaerts V
    Pharm Res; 1994 Jun; 11(6):869-74. PubMed ID: 7937528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability and controlled release of I-ascorbic acid encapsulated in poly (ethyl-2-cyanoacrylate) nanocapsules prepared by interfacial polymerization of water-in-oil microemulsions.
    Zhang SN; Chen T; Guo YG; Zhang J; Song X; Zhou L
    J Cosmet Sci; 2015; 66(4):247-59. PubMed ID: 26665980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of poly(butyl 2-cyanoacrylate) nanoparticles.
    Alonso MJ; Sanchez A; Torres D; Seijo B; Vila-Jato JL
    J Microencapsul; 1990; 7(4):517-26. PubMed ID: 1702468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions.
    Watnasirichaikul S; Rades T; Tucker IG; Davies NM
    Int J Pharm; 2002 Mar; 235(1-2):237-46. PubMed ID: 11879758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides.
    Lambert G; Fattal E; Pinto-Alphandary H; Gulik A; Couvreur P
    Pharm Res; 2000 Jun; 17(6):707-14. PubMed ID: 10955845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfacial properties of polymethyl alpha-cyanoacrylate and polybutyl alpha-cyanoacrylate.
    Florence AT; Haq ME; Johnson JR
    J Pharm Pharmacol; 1976 Jul; 28(7):539-43. PubMed ID: 8604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles.
    Chauvierre C; Labarre D; Couvreur P; Vauthier C
    Pharm Res; 2003 Nov; 20(11):1786-93. PubMed ID: 14661923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides.
    Lambert G; Fattal E; Pinto-Alphandary H; Gulik A; Couvreur P
    Int J Pharm; 2001 Feb; 214(1-2):13-6. PubMed ID: 11282229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of external phase on D-cycloserine loaded W/O nanocapsules prepared by the interfacial polymerization method.
    Musumeci T; Ventura CA; Carbone C; Pignatello R; Puglisi G
    Eur J Med Chem; 2011 Jul; 46(7):2828-34. PubMed ID: 21530017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monolayer studies on poly(isobutylcyanoacrylate)-ampicillin association.
    Baszkin A; Couvreur P; Deyme M; Henry-Michelland S; Albrecht G
    J Pharm Pharmacol; 1987 Dec; 39(12):973-7. PubMed ID: 2894444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
    Peracchia MT; Vauthier C; Passirani C; Couvreur P; Labarre D
    Life Sci; 1997; 61(7):749-61. PubMed ID: 9252249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats.
    Ammoury N; Fessi H; Devissaguet JP; Dubrasquet M; Benita S
    Pharm Res; 1991 Jan; 8(1):101-5. PubMed ID: 2014197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization.
    Krauel K; Davies NM; Hook S; Rades T
    J Control Release; 2005 Aug; 106(1-2):76-87. PubMed ID: 15967536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of antigen encapsulated in polyethylcyanoacrylate nanoparticles by D1-dendritic cells.
    Pitaksuteepong T; Davies NM; Baird M; Rades T
    Pharmazie; 2004 Feb; 59(2):134-42. PubMed ID: 15025183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow release polymer-drug systems obtained by moisture promoted polyreactions. 1. Codeine resinate encapsulated in poly(alkyl alpha-cyanoacrylates).
    Lukaszczyk J; Urbaś P
    J Microencapsul; 1998; 15(5):609-20. PubMed ID: 9743916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue.
    Damgé C; Vonderscher J; Marbach P; Pinget M
    J Pharm Pharmacol; 1997 Oct; 49(10):949-54. PubMed ID: 9364401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding instability and rupture of poly(alkyl-2-cyanoacrylate) capsules.
    Wischke C; Weigel J; Neffe AT; Lendlein A
    Int J Artif Organs; 2011 Feb; 34(2):243-8. PubMed ID: 21374580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.